SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One):[ ]Form 10-K [ ]Form 11-K [ ]Form 20-F [X] Form 10-Q
[ ] Form N-SAR
For Period Ended: March 31, 1999
[ ] Transition Report on Form 10-K [ ] Transition
Report on Form 10-Q
[ ] Transition Report on Form 2-F [ ] Transition Report on
Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:
Read attached instruction sheet before preparing form.
Please print or type.
Nothing in this form shall be construed to imply that the
Commission has verified any information contained herein.
If the notification relates to a portion of the filing
checked above, identify the item(s) to which the notification
relates:
PART I
REGISTRANT INFORMATION
Full name of registrant: Medical Device Alliance Inc.
Former name if applicable: N/A
Address of principal executive office (Street and number)
3800 Howard Hughes Parkway, Suite 1800
City, state and zip code Las Vegas, Nevada 89109
PART II
RULE 12b-25 (b) AND (C)
If the subject report could not be filed without unreasonable
effort or expense and the registrant seeks relief pursuant to
Rule 12b-25 (b), the following should be completed. (Check box if
appropriate.)
[X] (a) The reasons described in reasonable detail in Part III
of this form could not be eliminated without unreasonable
effort or expense;
[ ] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion
thereof will be filed on or before the 15th calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following
the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by
Rule 12b-25 (c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K,
20-F, 10-Q, N-SAR or the transition report portion thereof could
not be filed within the prescribed time period. (Attach extra
sheets if needed.)
The Company is involved in legal actions, the most significant
being a patent infringement dispute which trial commenced in
January 1999. These and other significant factors have been
disclosed in previous filings with the Securities and Exchange
Commission (including on a Form 12b-25 filed on March 26, 1999,
related to the Company's Form 10-KSB for the year ended December
31, 1998) and have caused, among other things, a significant
burden on management and reductions in the employee base,
including the loss of two controllers since December 1998 at
LySonix Incorporated, the most significant operating subsidiary
of the Company. These factors have delayed the examination of
the Company's 1998 consolidated financial statements by its
independent accountants and made it to where the filing of the
Company's Form 10-QSB by the prescribed due date cannot be
accomplished without the incurrence of unreasonable effort and
expense.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to
this notification:
Charles E. Barrantes (702) 791-2910
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section
13 or 15(d) of the Securities Exchange Act of 1934 or
Section 30 of the Investment Company Act of 1940 during the
preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed?
If the answer is no, identify report(s).
[ ] Yes [X] No
Form 10-KSB for the year ended December 31, 1998 (see Part
III)
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in
the subject report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the
reasons why a reasonable estimate of the results cannot be made.
MEDICAL DEVICE ALLIANCE INC.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by
the undersigned thereunto duly authorized.
Date May 13, 1999 By /s/ Charles E. Barrantes
